Federal Register - February 24, 2021
Versione di testo Cosa è?Dateas è un sito indipendente non affiliato a entità governative. La fonte dei documenti PDF che pubblichiamo qui è l'entità governativa indicata in ciascuno di essi. Le versioni in testo sono trascrizioni che realizziamo per facilitare l'accesso e la ricerca di informazioni, ma possono contenere errori o non essere complete.
Source: Federal Register
11333
Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices Controlled substance
Drug code
Anileridine
Diphenoxylate
Ecgonine
Levorphanol
Meperidine
Meperidine Intermediate-A
Meperidine Intermediate-B
Meperidine Intermediate-C
Dextropropoxyphene
Levo-alphacetylmethadol
Alfentanil
Remifentanil
Sufentanil
Carfentanil
Tapentadol
Fentanyl
William T. McDermott, Assistant Administrator.
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: 1 Drug Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and 2 Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
FR Doc. 2021-03758 Filed 2-21; 8:45 am
SUPPLEMENTARY INFORMATION:
The company plans to manufacture the above listed controlled substances as analytical reference materials, proficiency test materials and academic research materials for distribution to its customers. No other activities for these drug codes are authorized for this registration.
In accordance with 21 CFR 1301.34a, this is notice that on September 30, 2020, Globyz Pharma, LLC, 2101 Market Street, Suite 5, Upper Chichester, Pennsylvania 190614001, applied to be registered as an importer of the following basic classes of controlled substances:
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Docket No. DEA790
Importer of Controlled Substances Application: Globyz Pharma, LLC
Drug Enforcement Administration, Justice.
ACTION: Notice of application.
Controlled substance
Drug code
Schedule
Oxycodone
9143
II
AGENCY:
Globyz Pharma, LLC has applied to be registered as an importer of basic classes of controlled substances. Refer to Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 26, 2021. Such persons may also file a written request for a hearing on the application on or before March 26, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator,
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:21 Feb 23, 2021
Jkt 253001
The company plans to import the listed controlled substance to complete analytical testing. No other activity for these drug codes is authorized for this registration.
Approval of permit applications will occur only when the registrants business activity is consistent with what is authorized under 21 U.S.C. 952a2.
Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale.
William T. McDermott, Assistant Administrator.
FR Doc. 202103834 Filed 22321; 8:45 am BILLING CODE 441009P
PO 00000
Frm 00117
Fmt 4703
Sfmt 4703
9020
9170
9180
9220
9230
9232
9233
9234
9273
9648
9737
9739
9740
9743
9780
9801
Schedule II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
DEPARTMENT OF LABOR
Mine Safety and Health Administration Petitions for Modification of Application of Existing Mandatory Safety Standards Mine Safety and Health Administration, Labor.
ACTION: Notice.
AGENCY:
This notice is a summary of a petition for modification submitted to the Mine Safety and Health Administration MSHA by the party listed below.
DATES: All comments on the petition must be received by MSHAs Office of Standards, Regulations, and Variances on or before March 26, 2021.
ADDRESSES: You may submit your comments, identified by docket number on the subject line, by any of the following methods:
1. Electronic Mail: zzMSHAcomments@dol.gov. Include the docket number of the petition in the subject line of the message.
2. Facsimile: 2026939441.
3. Regular Mail or Hand Delivery:
MSHA, Office of Standards, Regulations, and Variances, 201 12th Street South, Suite 4E401, Arlington, Virginia 222025452, Attention: S.
Aromie Noe, Acting Deputy Director, Office of Standards, Regulations, and Variances. Persons delivering documents are required to check in at the receptionists desk in Suite 4E401.
Individuals may inspect copies of the petition and comments during normal business hours at the address listed above.
MSHA will consider only comments postmarked by the U.S. Postal Service or proof of delivery from another delivery service such as UPS or Federal Express on or before the deadline for comments.
SUMMARY:
E:FRFM24FEN1.SGM
24FEN1